Latest news with #SaiLifeSciences
Business Standard
5 hours ago
- Business
- Business Standard
Sai Life Sciences rises on completion of second phase expansion at Bidar facility
Sai Life Sciences rose 1.82% to Rs 742.45 after the company announced the successful commencement of commercial operations for the second phase of the production block at its Unit IV facility in Bidar, Karnataka. The new phase, which became operational on 19 June 2025, adds approximately 91 kL of production capacity. This marks the second and final phase of the total planned capacity addition of approximately 195 kL at the facility, as disclosed in the companys prospectus. With this addition, the total installed capacity at Unit IV now stands at approximately 640 kL. The expanded facility is equipped to manufacture Registered Starting Materials (RSM), intermediates, and Active Pharmaceutical Ingredients (APIs) for both clinical and commercial applications. Hyderabad-based Sai Life Sciences is a leading global contract research, development, and manufacturing organization (CRDMO) that partners with innovator pharmaceutical and biotech companies to accelerate the discovery, development, and commercialization of new medicines. The company offers integrated solutions spanning medicinal chemistry, process development, clinical and commercial manufacturing, and advanced technology platforms. The company's net profit surged 105% to Rs 170 crore on a 16% increase in revenue from operations to Rs 1,695 crore in Q4 March 2025 over Q4 March 2024.
Business Upturn
8 hours ago
- Business
- Business Upturn
Sai Life Sciences begins commercial operations of expanded Unit IV facility in Bidar
Sai Life Sciences has recently informed exchanges that the company successfully commenced commercial operations of the second phase of its production block at the Unit IV facility in Bidar, Karnataka, as of June 19, 2025. This phase adds around 91 kL of manufacturing capacity, marking the completion of the company's planned 195 kL expansion project at the site, as outlined in its prospectus. With this addition, the total installed capacity at the Bidar facility now stands at approximately 640 kL. The expanded unit is fully equipped to manufacture Registered Starting Materials (RSMs), intermediates, and Active Pharmaceutical Ingredients (APIs), catering to both clinical development and commercial-scale supply. This strategic milestone strengthens Sai Life Sciences' manufacturing footprint and aligns with its long-term growth plans in the pharmaceutical sector. The company's enhanced infrastructure will support its global clientele with high-quality and scalable production capabilities. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
&w=3840&q=100)
Business Standard
8 hours ago
- Business
- Business Standard
Sai Life Sciences up 5% amid heavy volume; 20.9 mn shares change hands
Sai Life Sciences shares spiked 5.1 per cent in trade on Friday, June 20, 2025, logging an intraday high at ₹766.55 per share on BSE. The northward movement in the stock came amid large trade. On BSE, at 10:51 AM, 20.95 million shares changed hands. However, around the same time, Sai Life share price pared some gains and was trading 1.11 per cent higher at ₹737.3 per share on the BSE. In comparison, the BSE Sensex was up 0.83 per cent at 82,040.39. The company's market capitalisation stood at ₹15,371.64 crore. Its 52-week high was at ₹808.2 per share and 52-week low was at ₹635.3 per share. Sai Life Sciences block deal details According to Bloomberg data, 20.8 million shares changed hands in Sai Life Sciences in a large block deal that implied 10 per cent equity. The buyers and sellers of the deal were not known. Besides, reportedly, TPG Asia was likely to sell a 6 per cent stake through block deals at a floor price of ₹710 per share at a discount of 2.6 per cent from the previous close. As of the quarter ended March 31, 2025, TPG Asia held a 24.73 per cent stake in the company. Apart from that, among foreign companies, HBM Private Equity India held a 1.99 per cent stake, according to the BSE shareholding pattern. ALSO READ | Sai Life Sciences financial performance in Q4 Sai Life Sciences reported a 57.26 per cent increase in net profit for the quarter that ended March 2025, rising to ₹88.27 crore from ₹56.13 crore in the same period last year. Revenue for the quarter also saw strong growth, rising 31.94 per cent to ₹579.51 crore from ₹439.21 crore. For the full financial year ending March 2025, net profit surged 105.45 per cent to ₹170.13 crore, up from ₹82.81 crore in FY24. Annual revenue rose 15.66 per cent year-on-year to ₹1,694.57 crore, compared to ₹1,465.18 crore the previous year. ALSO READ | About Sai Life Sciences Sai Life Sciences is a leading global Contract Research, Development, and Manufacturing Organization (CRDMO) that partners with innovative pharmaceutical and biotech companies to accelerate the discovery, development, and commercialization of new medicines. Headquartered in Hyderabad, India, with a strong global presence, the company offers integrated solutions spanning medicinal chemistry, process development, clinical and commercial manufacturing, and advanced technology platforms. Sai Life Sciences is committed to delivering high-quality, cost-effective, and scalable solutions while upholding the highest standards of safety, compliance, and integrity. With a focus on innovation and operational excellence, the company continues to strengthen its capabilities to support emerging therapeutic modalities and meet the evolving needs of the life sciences industry.
&w=3840&q=100)
Business Standard
13 hours ago
- Business
- Business Standard
Stocks to Watch today, June 20: HDFC Bk, Nestle, Concor, Sai Life Sciences
Stocks to Watch today, June 20: Indian equities are poised for a flat start as speculation over potential US intervention in West Asia has grabbed the market's attention. Last seen, GIFT Nifty futures were down 14 points at 24,789. On Thursday, reportedly, Israel bombed nuclear targets in Iran and Iran fired missiles and drones at Israel after hitting an Israeli hospital overnight, as a week-old air war escalated with no sign yet of an exit strategy from either side. Meanwhile, the White House said US President Donald Trump will make a decision within the next two weeks whether to get involved on Israel's side. Global markets were mixed post the developments. On the Asia-Pacific front, last checked, mainland China's CSI 300 was up 0.18 per cent, Hong Kong's Hang Seng up 0.23 per cent, Japan's Nikkei flat, and Australia's ASX 200 down 0.38 per cent. Overnight, futures tied to the Dow Jones Industrial Average slipped 154 points, or 0.3 per cent. Nasdaq 100 futures ticked down 0.2 per cent, while S&P 500 futures fell 0.2 per cent. Regular trading was closed in the US on Thursday for the Juneteenth holiday. CATCH STOCK MARKET UPDATES LIVE TODAY Here is a list of stocks to watch today, Friday, June 20, 2025: Block deal alert: Sai Life Sciences: Reportedly, TPG Asia is likely to sell 6 per cent stake through block deals at a floor price of ₹710 per share at a discount of 2.5 per cent from current market price (CMP). The offer size of the deal at ₹887.8 crore. HDFC Bank: Non-banking arm unit of HDFC Bank, HDB Financial Services has fixed its initial public offering's (IPO's) price band at ₹700 to ₹740 per equity share of face value of ₹10 each. Consequently, the minimum bid lot for the IPO has been fixed at 20 shares and applications may be made in multiples of 20 thereafter. HDB Financial Services IPO will open on June 25, 2025, and will conclude on June 27. Nestle India: The board is scheduled to consider a bonus share issue on June 26. Meanwhile, Nestle and IndusInd Bank will be removed from the BSE Sensex on June 23 as part of the index's rebalancing. They will be replaced by Trent and Bharat Electronics, both gaining visibility after their inclusion in the Nifty 50, adding momentum to index-linked fund interest. Container Corporation of India: Concor has set July 4, 2025, as the record date for its 1:4 bonus share issue. Hindustan Aeronautics: HAL's board is set to mull final dividend for FY25 on June 27. Kaynes Technology India: The company launched its qualified institutional placement (QIP) at a floor price of ₹5,625.75 per share. ITD Cementation: The company has secured two new contracts worth ₹960 crore. Ashoka Buildcon: The company has received a Letter of Acceptance (LoA) from the Government of Guyana, Public Works Department for a project worth $67 million. LTIMindtree: The company has announced the launch of its new business, BlueVerse, an integrated AI platform that helps businesses fast-track their AI transformation journeys. HCL Technologies: The company has been roped in by Just Energy, a major US energy retailer, to overhaul its customer operations and enterprise systems. Maruti Suzuki: The auto company has stocks of rare earth magnets imported from China that will last only until the end of July. The company will prepare a contingency plan, including exploring alternatives if the ongoing issue remains unresolved by then. TCS: Tata Consultancy Services (TCS) has clarified at its 30th annual general meeting (AGM) that the company is not under investigation in relation to the recent cyber breach at one of its largest retail clients, Marks & Spencer. Wipro: The IT company has leased 3.87 lakh square feet (sq ft) of office space at Mindspace Business Park in the Mumbai Metropolitan Region (MMR) for a tenure of 10 years, according to lease-related documents provided by Propstack, a real estate data analytics firm. Mastek: The digital engineering and cloud transformation partner, announced the launch of a comprehensive suite of AI solutions and services aimed at accelerating AI innovation and driving enterprise-wide AI adoption. Brigade Enterprises: Brigade Group's workspace brand, BuzzWorks, signed up for a 24,000 sq. ft. workspace at Auro Orbit, HITEC City. Uno Minda: The company's board approved the setting up of a greenfield manufacturing facility for aluminium die casting in Sambhaji Nagar (Aurangabad) Maharashtra. The project involves a total planned capital investment of approximately ₹210 crore, to be implemented in a phased manner over the next five years. Adani Power: The approved National Company Law Tribunal (NCLT), bench at Mumbai approved the company's resolution plan for acquisition of VIPL, a company undergoing the corporate insolvency resolution process under the Insolvency and Bankruptcy Code. Crisil: The company has invested ₹33.25 crore to acquire a minority stake in Online PSB Loans Ltd (OPL). In December 2024, Crisil had announced its intention to invest. Samvardhana Motherson International: The board has approved the execution of Power Delivery Agreements (PDA) with HR Dhauliganga Private Limited (HRDPL), by the company and its subsidiaries.
Mint
14 hours ago
- Business
- Mint
Stocks to watch: Nestle, HDFC Bank, HCL Tech, CONCOR among shares in focus today
FMCG giant Nestle India has scheduled a board meeting on June 26 to review and approve a proposal for issuing bonus shares. Global asset management firm TPG is expected to divest 12.5 million shares, amounting to a 6% stake in Sai Life Sciences, in a deal estimated to be worth around $102 million (approximately ₹ 885 crore). The non-banking subsidiary of HDFC Bank has finalized the dates for its highly awaited ₹ 12,500 crore IPO, which is scheduled to open from June 25 to June 27. According to reports, Kaynes Technology has launched its qualified institutional placement (QIP) offering to raise up to ₹ 1,600 crore. The technology giant, a subsidiary of the Larsen & Toubro Group, introduced BlueVerse — a unified AI platform designed to accelerate AI transformation for businesses. CONCOR, the state-owned logistics company, has announced July 4, 2025, as the record date for its 1:4 bonus share issue, offering a potential long-term benefit for retail investors. Goldman Sachs offloaded more than 1.77 lakh shares of Ethos through a block deal valued at ₹ 48 crore, with the shares being sold at a price of ₹ 2,700.6 each. The US FDA issued a Form 483 containing seven observations for the company's pharmaceutical division located in Kothur, Hyderabad. The infrastructure company has officially entered into a $67.25 million ( ₹ 562 crore) agreement with the Government of Guyana for Phase 2 of the East Bank–East Coast Road Linkage Project. The technology solutions company has entered into a strategic Memorandum of Understanding (MoU) with Aldoria, a European leader in Space Surveillance and Situational Awareness (SSA), to enhance India's rapidly growing space capabilities. Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions.
